Education
About Us
Working with TipRanks
Follow Us
Protalix Biotherapeutics (PLX)
:PLX
Total Valuation
Protalix has a market cap or net worth of $143.15M. The enterprise value is $158.22M.
Market Cap$143.15M
Enterprise Value$158.22M
Share Statistics
Protalix has 80,421,180 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding80,421,180
Owned by Insiders3.84%
Owned by Institutions4.60%
Financial Efficiency
Protalix’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.61%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.61%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee250.70K
Profits Per Employee13.77K
Employee Count213
Asset Turnover0.73
Inventory Turnover1.14
Valuation Ratios
The current PE Ratio of Protalix is 25.6. Protalix’s PEG ratio is -0.70.
PE Ratio25.6
PS Ratio2.55
PB Ratio3.16
Price to Fair Value3.16
Price to FCF18.45
Price to Operating Cash Flow-14.15
PEG Ratio-0.70
Income Statement
In the last 12 months, Protalix had revenue of 53.40M and earned 2.93M in profits. Earnings per share was 0.04.
Revenue53.40M
Gross Profit29.08M
Operating Income3.92M
Pretax Income4.15M
Net Income2.93M
EBITDA6.52M
Earnings Per Share (EPS)0.04
Cash Flow
In the last 12 months, operating cash flow was -10.03M and capital expenditures -1.66M, giving a free cash flow of -11.69M billion.
Operating Cash Flow-10.03M
Free Cash Flow-11.69M
Free Cash Flow per Share-0.15
Dividends & Yields
Protalix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change3.66%
50-Day Moving Average2.17
200-Day Moving Average2.00
Relative Strength Index (RSI)36.19
Average Volume (3m)612.25K
Important Dates
Protalix upcoming earnings date is Mar 12, 2026, TBA (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateMar 12, 2026
Ex-Dividend Date―
Financial Position
Protalix as a current ratio of 2.34, with Debt / Equity ratio of 10.92%
Current Ratio2.34
Quick Ratio1.52
Debt to Market Cap0.00
Net Debt to EBITDA-2.18
Interest Coverage Ratio3.69
Taxes
In the past 12 months, Protalix has paid 1.22M in taxes.
Income Tax1.22M
Effective Tax Rate0.29
Enterprise Valuation
Protalix EV to EBITDA ratio is 18.73, with an EV/FCF ratio of 16.52.
EV to Sales2.29
EV to EBITDA18.73
EV to Free Cash Flow16.52
EV to Operating Cash Flow14.08
Balance Sheet
Protalix has $29.37M in cash and marketable securities with $8.18M in debt, giving a net cash position of $21.19M billion.
Cash & Marketable Securities$29.37M
Total Debt$8.18M
Net Cash$21.19M
Net Cash Per Share$0.26
Tangible Book Value Per Share$0.60
Margins
Gross margin is 42.13%, with operating margin of 7.34%, and net profit margin of 5.49%.
Gross Margin42.13%
Operating Margin7.34%
Pretax Margin7.78%
Net Profit Margin5.49%
EBITDA Margin12.21%
EBIT Margin9.77%
Analyst Forecast
The average price target for Protalix is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$12.00
Price Target Upside574.16% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast35.42%
EPS Growth Forecast―